Potentially fatal asthma (Q43766164)

26 November 2017

1 reference

title

[Potentially fatal asthma]. (English)

1 reference

26 November 2017

0 references

L J Nannini

1 reference

26 November 2017

language of work or name

Spanish

0 references

publication date

1 October 1997

1 reference

Archivos de Bronconeumologia

26 November 2017

published in

1 reference

26 November 2017

1 reference

26 November 2017

1 reference

26 November 2017

page(s)

462-471

1 reference

History of asthma deaths from antiquity

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

International trends in asthma mortality: 1970 to 1985.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Determinants of near fatality in acute severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Demographic characteristics of patients with severe life threatening asthma: comparison with asthma deaths

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

A comparison of asthma deaths and near-fatal asthma attacks in South Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Ventilation Response and Drive during Hypoxia in Adult Patients with Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Occlusion pressure as a measure of respiratory center output cm conscious man

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Reduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Fatal and near-fatal asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

The use of beta-agonists and the risk of death and near death from asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Regular inhaled beta-agonist treatment in bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Questions about inhaled beta 2-adrenoceptor agonists in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Chronic fenoterol exposure increases in vivo and in vitro airway responses in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Inhaled beta-adrenergic receptor agonists in asthma: more harm than good?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Respiratory arrest in near-fatal asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Regular inhaled salbutamol and airway responsiveness to allergen

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Neuromuscular manifestations of electrolyte disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Metabolic acidosis in status asthmaticus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Fenoterol and serum potassium

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Frequently nebulized beta-agonists for asthma: effects on serum electrolytes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Asthma requiring mechanical ventilation. A low morbidity approach

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

The fatality-prone asthmatic patient. Follow-up study after near-fatal attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Community outbreaks of asthma associated with inhalation of soybean dust. Toxicoepidemiological Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Identification of soybean dust as an epidemic asthma agent in urban areas by molecular marker and RAST analysis of aerosols.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Barcelona's asthma epidemics: clinical aspects and intriguing findings

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Aspirin-sensitive asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Improvement in aspirin-sensitive asthmatic subjects after rapid aspirin desensitization and aspirin maintenance (ADAM) treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Effect of inhaled preservatives on asthmatic subjects. I. Sodium metabisulfite

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Characterisation of bronchoconstrictor responses to sodium metabisulphite aerosol in atopic subjects with and without asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Effect of inhaled magnesium sulfate on sodium metabisulfite-induced bronchoconstriction in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Mechanisms of metabisulfite-induced bronchoconstriction: evidence for bradykinin B2-receptor stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Comparison of sulphur dioxide and metabisulphite airway reactivity in subjects with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

EFFECT OF A β-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Involvement of thromboxane A2 in propranolol-induced bronchoconstriction after allergic bronchoconstriction in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

NHLBI Workshop summary. Stress and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Aetiology of asthma: lessons from lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

A case-control study of deaths from asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

1 reference

7 January 2021

Prevention of fatal asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

The assessment and management of adults with status asthmaticus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Use of a measurement of pulmonary hyperinflation to control the level of mechanical ventilation in patients with acute severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Permissive hypercapnia. How permissive should we be?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Combined ventilator and bicarbonate strategy in the management of status asthmaticus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Inhaled glucocorticoids for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Regular beta-adrenergic agonists. Evidence, not reassurance, is what is needed

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Intravenous magnesium sulfate in the management of acute respiratory failure complicating asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Intravenous magnesium sulfate in acute, life-threatening asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

High-dose intravenous magnesium sulfate in the management of life-threatening status asthmaticus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Treatment of status asthmaticus with intravenous magnesium sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Noninvasive face mask mechanical ventilation in patients with acute hypercapnic respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Enflurane and halothane in status asthmaticus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Heliox therapy in acute severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Extracorporeal life support for status asthmaticus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Extracorporeal life support for status asthmaticus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Near fatal asthma attacks: the reliability of descriptive information collected from close acquaintances

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Near-fatal asthma: Clinical and physiologic features, perception of bronchoconstriction, and psychologic profile

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Assisted ventilation in severe acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Acute severe asthma treated by mechanical ventilation: 10 years' experience from a district general hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

The diagnosis of potentially fatal asthma in hospitalized adults. Patient characteristics and increased severity of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Treatment of status asthmaticus. A report of 70 episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Sudden asphyxic asthma: a distinct entity?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Identification of the high-risk asthmatic patient. Experience with 39 patients undergoing ventilation for status asthmaticus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Muscle weakness in mechanically ventilated patients with severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

Which PEF value is the best?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930550-0

7 January 2021

10.1016/S0300-2896(15)30550-0

Identifiers

DOI

1 reference

26 November 2017

1 reference